Radius Health, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding, Public
- Established
- 2003-11-01
- Employees
- 293
- Market Cap
- -
- Website
- http://radiuspharm.com
Clinical Trials
33
Active:21
Completed:12
Trial Phases
3 Phases
Phase 1:16
Phase 2:2
Phase 3:5
Drug Approvals
2
FDA:2
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
Phase 1
16 (69.6%)Phase 3
5 (21.7%)Phase 2
2 (8.7%)Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 22054
- Registration Number
- NCT04974723
- Locations
- 🇺🇸
Radius Health, Boston, Massachusetts, United States
Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.
Phase 1
Completed
- Conditions
- Osteoporosis
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT04936984
- Locations
- 🇺🇸
Medpace Clinical Pharmacology, Cincinnati, Ohio, United States
Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.
Phase 1
Completed
- Conditions
- Healthy Volunteers
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04663464
- Locations
- 🇺🇸
Medpace Clinical Pharmacology, Cincinnati, Ohio, United States
Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)
Phase 1
Completed
- Conditions
- Postmenopausal Osteoporosis
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04366726
- Locations
- 🇺🇸
Pharmaceutical Research Associates, Inc, Lenexa, Kansas, United States
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
Phase 3
Completed
- Conditions
- Postmenopausal Osteoporosis
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Radius Health, Inc.
- Target Recruit Count
- 511
- Registration Number
- NCT04064411
- Locations
- 🇺🇸
University of Alabama Hospital at Birmingham, Birmingham, Alabama, United States
🇺🇸Orthopedic Physician Alaska - Rheumatology, Anchorage, Alaska, United States
🇺🇸Arizona Arthritis & Rheumatology Research, PLLC - Research Center - Glendale, Glendale, Arizona, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found